Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...
Although group A streptococcus has not developed resistance, antibiotic therapy fails to eradicate the infection in some patients. Many authors have suggested using a cephalosporin as an ...
Novartis exited novel antibiotics R&D three years ago, but is clearly still interested in the category – its Sandoz unit has just spent $350 million buying GlaxoSmithKline’s cephalosporin ...
These will slot into Shionogi’s portfolio alongside Fetroja (cefiderocol), billed as the first and only siderophore cephalosporin antibiotic that has a novel mechanism for penetrating the outer ...